Keywords: Singapore, Pharmaceutical market, BMI, Biomedical hub, Clinical trials, CROs

Slow growth of 3.4% a year forecast for Singapore pharma market, which will reach value of $705 million in 2014

Article | 18 May 2010

Having moved up from eighth in the fourth quarter of 2009 to seventh in first-quarter 2010, Singapore is now placed ninth (of 15) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in